A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development
- PMID: 14597552
- DOI: 10.1096/fj.03-0483fje
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development
Abstract
The involvement of interleukin-1 (IL-1) in inflammation, tumor growth, and metastasis makes it an attractive target for therapeutic intervention. Here, we show that a continuous delivery of a low, but steady-state level of the naturally occurring IL-1 receptor antagonist (IL-1Ra) reduced inflammatory responses and inhibited tumor development in mice, phenomena that are induced by IL-1, mainly secretable IL-1beta. The IL-1Ra was delivered from microencapsulated genetically engineered cells, which overexpress and secrete this mediator. For a tumor model, we used fibrosarcoma cell line, which secretes high levels of IL-1beta; when injected s.c. into mice, the cells developed into large tumors characterized by very active angiogenic patterns. The proangiogenic features of IL-1beta were manifested at low levels of the cytokine, and release of 25 ng per day of the IL-1Ra was needed to oppose its effects and inhibit tumor development. The continuous delivery of the IL-1Ra contributed to improved biocompatibility of the microencapsulated cell systems; the fibrotic sac surrounding the systems was much thinner with significantly less blood capillaries and inflammatory cells. Not only do our findings point to the antiangiogenic properties of IL-1Ra in inflammation and tumor growth, but they also provide a more efficient and convenient way for treating diseases involving IL-1.
Similar articles
-
Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.J Control Release. 2007 Nov 6;123(2):123-30. doi: 10.1016/j.jconrel.2007.07.015. Epub 2007 Aug 7. J Control Release. 2007. PMID: 17900737
-
Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.Cancer Res. 2003 Sep 15;63(18):5957-61. Cancer Res. 2003. PMID: 14522922
-
Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.Cancer Res. 2011 Jan 1;71(1):51-60. doi: 10.1158/0008-5472.CAN-10-2289. Epub 2010 Nov 19. Cancer Res. 2011. PMID: 21097717
-
Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.Cancer Res. 2007 Feb 1;67(3):1062-71. doi: 10.1158/0008-5472.CAN-06-2956. Cancer Res. 2007. PMID: 17283139
-
Role of IL-1-mediated inflammation in tumor angiogenesis.Adv Exp Med Biol. 2007;601:265-70. doi: 10.1007/978-0-387-72005-0_28. Adv Exp Med Biol. 2007. PMID: 17713014 Review.
Cited by
-
Unique Versus Redundant Functions of IL-1α and IL-1β in the Tumor Microenvironment.Front Immunol. 2013 Jul 8;4:177. doi: 10.3389/fimmu.2013.00177. eCollection 2013. Front Immunol. 2013. PMID: 23847618 Free PMC article.
-
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.J Clin Invest. 2005 Nov;115(11):2979-91. doi: 10.1172/JCI23298. Epub 2005 Oct 20. J Clin Invest. 2005. PMID: 16239969 Free PMC article.
-
Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women.Eur J Clin Nutr. 2019 Sep;73(9):1250-1259. doi: 10.1038/s41430-019-0396-y. Epub 2019 Jan 28. Eur J Clin Nutr. 2019. PMID: 30692654
-
IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis.J Exp Med. 2012 Aug 27;209(9):1689-702. doi: 10.1084/jem.20101355. Epub 2012 Aug 20. J Exp Med. 2012. PMID: 22908325 Free PMC article.
-
Absence of PAF actions increases angiogenesis.Br J Pharmacol. 2004 Apr;141(7):1085-6. doi: 10.1038/sj.bjp.0705728. Epub 2004 Mar 15. Br J Pharmacol. 2004. PMID: 15023858 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
